Dehydro Nystatin - Request Quote
Dehydro Nystatin
| SZ CAT No: | SZ-N039011 |
| CAS No | NA |
| Mol.F. | C47H73NO16 |
| Mol.Wt. | 908.1 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Dehydro Nystatin is chemically (1R,3R,4R,7R,9R,11R,15S,16R,17R,18S,19E,21E,25E,27E,29E,31E,33R,35S,36R)-33-(((2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-1,3,4,7,9,11,17-heptahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,25,27,29,31,37-heptaene-36-carboxylic acid. Dehydro Nystatin is supplied with detailed characterization data compliant with regulatory guideline. Dehydro Nystatin can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Nystatin.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Dehydro Nystatin
Purchase Dehydro Nystatin
Dehydro Nystatin suppliers
Dehydro Nystatin manufacturers
Dehydro Nystatin price
Order Dehydro Nystatin
Enquire Dehydro Nystatin
Dehydro Nystatin cost
Dehydro Nystatin Supplier
Dehydro Nystatin Distributor
Dehydro Nystatin for Method Validation
Nystatin Reference Standard
Dehydro Nystatin for ANDA Filing
Dehydro Nystatin for Forced Degradation Studies
Dehydro Nystatin Identification Standards
Dehydro Nystatin for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


